Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.

Publication Type:

Journal Article

Source:

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Volume 28, Issue 22, p.3611-6 (2010)

Keywords:

2010, ADENOCARCINOMA, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Attitude to Health, Center-Authored Paper, Deoxycytidine, Female, Humans, Male, Mental Health, Middle Aged, Pain, Pancreatic Neoplasms, Public Health Sciences Division, Quality of Life

Abstract:

S0205 was a randomized clinical trial that compared the therapeutic impact of gemcitabine versus gemcitabine plus cetuximab. Study results for patient-reported health-related quality of life (HRQL) outcomes are reported.